Differences in Host Susceptibility to Disease Progression in the Human Challenge Model of Haemophilus ducreyi Infection

Infection and Immunity

Volumn 71, Issue 11, 2003, Pages 6658-6663

  Spinola, Stanley M ^a   Bong, Cliffton T H ^a,b   Faber, Andrew L ^a   Fortney, Kate R ^a   Bennett, Stacy L ^a   Townsend, Carisa A ^a   Zwickl, Beth E ^a   Billings, Steven D ^a   Humphreys, Tricia L ^a   Bauer, Margaret E ^a   Katz, Barry P ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BINDING SITE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; HAEMOPHILUS DUCREYI; HOST SUSCEPTIBILITY; HUMAN; HUMAN EXPERIMENT; INOCULATION; MALE; NONHUMAN; NORMAL HUMAN; OUTCOMES RESEARCH; PHAGOCYTOSIS; PRIORITY JOURNAL; PUSTULE; REINFECTION; SERUM BACTERICIDAL ACTIVITY; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ADULT; BLOOD BACTERICIDAL ACTIVITY; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; HAEMOPHILUS DUCREYI; HAEMOPHILUS INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHAGOCYTOSIS; RETROSPECTIVE STUDIES; SUPPURATION;

EID: 0242318233     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.11.6658-6663.2003     Document Type: Article

References (50)

1. Ahmed, H. J., C. Johansson, L. A. Svensson, K. Ahlman, M. Verdrengh, and T. Lagergard. 2002. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes. Infect. Immun. 70:899-908.
2. Alhady, S. M. A., and K. Sivanantharajah. 1969. Keloids in various races. Plast. Reconstr. Surg. 44:564-566.
3. Al-Tawfiq, J. A., M. E. Bauer, K. R. Fortney, B. P. Katz, A. F. Hood, M. Ketterer, M. A. Apicella, and S. M. Spinola. 2000. A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection. J. Infect. Dis. 181:1176-1179.
4. Al-Tawfiq, J. A., J. Harezlak, B. P. Katz, and S. M. Spinola. 2000. Cumulative experience with Haemophilus ducreyi in the human model of experimental infection. Sex. Transm. Dis. 27:111-114.
5. Al-Tawfiq, J. A., K. L. Palmer, C.-Y. Chen, J. C. Haley, B. P. Katz, A. F. Hood, and S. M. Spinola. 1999. Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge. J. Infect. Dis. 179:1283-1287.
6. Al-Tawfiq, J. A., A. C. Thornton, B. P. Katz, K. R. Fortney, K. D. Todd, A. F. Hood, and S. M. Spinola. 1998. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J. Infect. Dis. 178:1684-1687.
7. Bauer, M. E., M. P. Goheen, C. A. Townsend, and S. M. Spinola. 2001. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect. Immun. 69:2549-2557.
8. Bauer, M. E., and S. M. Spinola. 2000. Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection. Infect. Immun. 68:2309-2314.
9. Bong, C. T. H., K. R. Fortney, B. P. Katz, A. F. Hood, L. R. San Mateo, T. H. Kawula, and S. M. Spinola. 2002. A superoxide dismutase C mutant of Haemophilus ducreyi is virulent in human volunteers. Infect. Immun. 70:1367-1371.
10. Bong, C. T. H., J. Harezlak, B. P. Katz, and S. M. Spinola. 2002. Men are more susceptible to pustule formation than women in the experimental model of Haemophilus ducreyi infection. Sex. Transm. Dis. 29:114-118.
11. Bong, C. T. H., R. E. Throm, K. R. Fortney, B. P. Katz, A. F. Hood, C. Elkins, and S. M. Spinola. 2001. A DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers. Infect. Immun. 69:1488-1491.
12. Cohen, M. S., and J. G. Cannon. 1999. Human experimentation with Neisseria gonorrhoeae: progress and goals. J. Infect. Dis. 179:S375-S379.
13. Cole, L. E., T. H. Kawula, K. L. Toffer, and C. Elkins. 2002. The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes. Infect. Immun. 70:6158-6165.
14. Donnenberg, M. S., C. O. Tacket, G. Losonsky, G. Frankel, J. P. Nataro, G. Dougan, and M. M. Levine. 1998. Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge. Infect. Immun. 66:52-58.
15. Elkins, C., K. J. Morrow, and B. Olsen. 2000. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA. Infect. Immun. 68:1608-1619.
16. Fortney, K. R., R. S. Young, M. E. Bauer, B. P. Katz, A. F. Hood, R. S. Munson, Jr., and S. M. Spinola. 2000. Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection. Infect. Immun. 68:6441-6448.
17. Freedman, D. O. 1991. Experimental infection of human subjects with Strongyloides species. Rev. Infect. Dis. 13:1221-1226.
18. Gelfanova, V., T. L. Humphreys, and S. M. Spinola. 2001. Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects. Infect. Immun. 69:4224-4231.
19. Hiltke, T. J., M. E. Bauer, J. Klesney-Tait, E. J. Hansen, R. S. Munson, Jr., and S. M. Spinola. 1999. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants. Microb. Pathog. 26:93-102.
20. Humphreys, T. L., C. T. Schnizlein-Bick, B. P. Katz, L. A. Baldridge, A. F. Hood, R. A. Hromas, and S. M. Spinola. 2002. Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J. Immunol. 169:6316-6323.
21. Jansson, L., and R. Holmdahl. 1998. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. Res. 47:290-301.
22. McGuirk, P., and K. H. G. Mills. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23:450-455.
23. Mecsas, J., B. Raupach, and S. Falkow. 1998. The Yersinia Yops inhibit invasion of Listeria, Shigella and Edwardsiella but not Salmonella into epithelial cells. Mol. Microbiol. 28:1269-1281.
24. Melby, P. C. 1991. Experimental leishmaniasis in humans: review. Rev. Infect. Dis. 13:1009-1017.
25. Miller, F. G., and C. Grady. 2001. The ethical challenge of infection-inducing challenge experiments. Clin. Infect. Dis. 33:1028-1033.
26. Modlin, R. L., J. Melancon-Kaplan, S. M. M. Young, C. Pirmez, H. Kino, J. Convit, T. H. Rea, and B. R. Bloom. 1988. Learning from lesions: patterns of tissue inflammation in leprosy. Proc. Natl. Acad. Sci. USA 85:1213-1217.
27. Niessen, F. B., M. P. Andriessen, J. Schalkwijk, L. Visser, and W. Timens. 2001. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J. Pathol. 194:207-216.
28. Nulsen, M. F., J. J. Finlay-Jones, and P. J. McDonald. 1986. T-lymphocyte involvement in abscess formation in nonimmune mice. Infect. Immun. 52:633-636.
29. Onderdonk, A. B., R. L. Cisneros, J. H. Crabb, R. W. Finberg, and D. L. Kasper. 1989. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber. Infect. Immun. 57:3030-3037.
30. Palmer, K. L., C. T. Schnizlein-Bick, A. Orazi, K. John, C.-Y. Chen, A. F. Hood, and S. M. Spinola. 1998. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J. Infect. Dis. 178:1688-1697.
31. Rosenbaum, J. R., and K. A. Sepkowitz. 2002. Infectious disease experimentation involving human volunteers. Clin. Infect. Dis. 34:963-971.
32. Sarvetnick, N., and H. S. Fox. 1990. Interferon-gamma and the sexual dimorphism of autoimmunity. Mol. Biol. Med. 7:323-331.
33. Schmidt, K. A., H. J. Schneider, J. A. Lindstrom, J. W. Boslego, R. A. Warren, L. VanDeVerg, C. D. Deal, J. B. McClain, and J. M. Griffiss. 2001. Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex. Transm. Dis. 28:555-564.
34. Shapiro, M. E., D. L. Kasper, D. F. Zaleznik, S. Spriggs, A. B. Onderdonk, and R. W. Finberg. 1986. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J. Immunol. 137:341-346.
35. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
36. Solar, D., T. L. Humphreys, S. M. Spinola, and J. J. Campbell. 2003. CCR4 versus CCR10 in human cutaneous Th lymphocyte trafficking. Blood 101:1677-1683.
37. Spellburg, B., and J. E. Edwards, Jr. 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32:76-102.
38. Spinola, S. M., M. E. Bauer, and R. S. Munson, Jr. 2002. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect. Immun. 70:1667-1676.
39. Spinola, S. M., A. Orazi, J. N. Arno, K. Fortney, P. Kotylo, C.-Y. Chen, A. A. Campagnari, and A. F. Hood. 1996. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J. Infect. Dis. 173:394-402.
40. Spinola, S. M., L. M. Wild, M. A. Apicella, A. A. Gaspari, and A. A. Campagnari. 1994. Experimental human infection with Haemophilus ducreyi. J. Infect. Dis. 169:1146-1150.
41. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
42. Throm, R. E., and S. M. Spinola. 2001. Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers. Infect. Immun. 69:1483-1487.
43. + T-cell activation via the CD28-B7-2 costimulatory pathway. Infect. Immun. 68:6650-6655.
44. Tzianabos, A. O., P. R. Russell, A. B. Onderdonk, F. C. Gibson III, C. Cywes, M. Chan, R. W. Finberg, and D. L. Kasper. 1999. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J. Immunol. 163:893-897.
45. Van Voorhis, W., L. Barrett, D. Koelle, J. Nasio, F. Plummer, and S. Lukehart. 1996. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J. Infect. Dis. 173:491-495.
46. Varga, J., and S. A. Jimenez. 1995. Modulation of collagen gene expressions: its relation to fibrosis in systemic sclerosis and other disorders. Ann. Intern. Med. 122:60-62.
47. Wannamaker, L. W. 1970. Differences between streptococcal infections of the throat and of the skin. N. Engl. J. Med. 282:23-31.
48. Wood, G. E., S. M. Dutro, and P. A. Totten. 2001. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line. Infect. Immun. 69:4726-4733.
49. Young, R. S., M. J. Filiatrault, K. R. Fortney, A. F. Hood, B. P. Katz, R. S. Munson, Jr., A. A. Campagnari, and S. M. Spinola. 2001. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of β-1,4-glucosyltransferase is virulent in humans. Infect. Immun. 69:4810-4814.
50. Young, R. S., K. Fortney, J. C. Haley, A. F. Hood, A. A. Campagnari, J. Wang, J. A. Bozue, R. S. Munson, Jr., and S. M. Spinola. 1999. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers. Infect. Immun. 67:6335-6340.